The federal-provincial-territorial aspect that I think Dr. Bennett started to allude to was the whole issue around what happens once a drug has been approved, some of the collaboration around making it available to patients. As we've always said, the funding of medications and the funding of even treatments and other diagnoses are pretty much provincial jurisdictions, and I think that part has not in fact continued to progress.
I would say that, unfortunately, part of it is a debate that patients have no appetite for, and that is the question of who is going to fund it. At the end of the day, Canada is going to fund it. And as we say, whether it comes out of our left pocket or whether it comes out of our right pocket, we as patients don't really care. We really urge the feds, the provinces, and the territories to get together, because we need to have you all at the table in order to do a national plan.
We, as the Canadian Organization for Rare Disorders, have been going around the country hosting patient consultations to talk about how to get better access. We've been educating patients on what the regulatory framework is, what the funding framework is, so they can provide input. We have been very pleased that whenever we held our round tables, we've had the feds and the provinces at the table, so we know you guys can get along with each other. We do know that can happen. And we do know that at the end of the day you have a shared vision.
We want to say that we need to have you talking about, as Gail said, whether there is a review process that you folks are actually intimately part of with the Canadian Agency for Drugs and Technologies in Health. I think you fund 75% of that body. Give a nod to them to get on with coming up with a mechanism for the approval of funding for drugs for rare disorders, for which, as you said, the recommendations can be used nationally, so we don't have different provinces coming up with different solutions.
We were talking about centres of excellence and centres of expertise. Yes, you've shown that you can make those kinds of strategic plans. You've done it for cancer, you've done it for cardiovascular disease, and you've done it for diabetes. You've put together these national strategies and said you will provide the guidance, the leadership, and the support for provinces to work together collaboratively to make it happen, and to work with the institutions--